These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 17689528)

  • 1. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
    Wong WS; Zhu H; Liao W
    Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of LTD(4)in allergic pulmonary inflammation in mice: modulation by cysLT(1)antagonist MK-571.
    Blain JF; Sirois P
    Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):361-8. PubMed ID: 10913229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
    Zhao J; Yeong LH; Wong WS
    Int Arch Allergy Immunol; 2007; 142(3):219-29. PubMed ID: 17108703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
    Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
    J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteome analysis of chronically inflamed lungs in a mouse chronic asthma model.
    Wong WS; Zhao J
    Int Arch Allergy Immunol; 2008; 147(3):179-89. PubMed ID: 18594147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cysteinyl leukotrienes in airway inflammation and responsiveness following RSV infection in BALB/c mice.
    Fullmer JJ; Khan AM; Elidemir O; Chiappetta C; Stark JM; Colasurdo GN
    Pediatr Allergy Immunol; 2005 Nov; 16(7):593-601. PubMed ID: 16238585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study to elucidate the mechanism underlying the difference in airway hyperresponsiveness between two mouse strains.
    Fukunaga J; Abe M; Murai A; Akitake Y; Hosokawa M; Takahashi M
    Int Immunopharmacol; 2007 Dec; 7(14):1852-61. PubMed ID: 18039522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model.
    Muraki M; Imbe S; Santo H; Sato R; Sano H; Iwanaga T; Tohda Y
    Int Arch Allergy Immunol; 2011; 155 Suppl 1():90-5. PubMed ID: 21646802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased lungkine and chitinase levels in allergic airway inflammation: a proteomics approach.
    Zhao J; Zhu H; Wong CH; Leung KY; Wong WS
    Proteomics; 2005 Jul; 5(11):2799-807. PubMed ID: 15996009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model.
    Kim DY; Ryu SY; Lim JE; Lee YS; Ro JY
    Eur J Pharmacol; 2007 Feb; 557(1):76-86. PubMed ID: 17169357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of Duchesnea chrysantha extract on ovalbumin-induced lung inflammation in a mouse model of asthma.
    Yang EJ; Lee JS; Yun CY; Kim JH; Kim JS; Kim DH; Kim IS
    J Ethnopharmacol; 2008 Jun; 118(1):102-7. PubMed ID: 18485641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selective cysteinyl leukotriene receptor antagonists on airway inflammation and matrix metalloproteinase expression in a mouse asthma model.
    Hsu CH; Hu CM; Lu KH; Yang SF; Tsai CH; Ko CL; Sun HL; Lue KH
    Pediatr Neonatol; 2012 Aug; 53(4):235-44. PubMed ID: 22964281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of montelukast on airway remodeling and the expression of interleukins and transforming growth factor-beta2 mRNA].
    Bai JW; Deng WW; Wu HC
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):524-8. PubMed ID: 15388000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
    Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.
    Henderson WR; Tang LO; Chu SJ; Tsao SM; Chiang GK; Jones F; Jonas M; Pae C; Wang H; Chi EY
    Am J Respir Crit Care Med; 2002 Jan; 165(1):108-16. PubMed ID: 11779739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade.
    Henderson WR; Chiang GK; Tien YT; Chi EY
    Am J Respir Crit Care Med; 2006 Apr; 173(7):718-28. PubMed ID: 16387808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3.
    Kiwamoto T; Ishii Y; Morishima Y; Yoh K; Kikuchi N; Haraguchi N; Masuko H; Kawaguchi M; Nomura A; Sakamoto T; Takahashi S; Hizawa N
    Clin Exp Allergy; 2011 Jan; 41(1):116-28. PubMed ID: 20636401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast modulates lung CysLT(1) receptor expression and eosinophilic inflammation in asthmatic mice.
    Zhang YJ; Zhang L; Wang SB; Shen HH; Wei EQ
    Acta Pharmacol Sin; 2004 Oct; 25(10):1341-6. PubMed ID: 15456537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of synthetic somatostatin receptor subtype 4 agonists on acute and chronic airway inflammation and hyperreactivity in the mouse.
    Elekes K; Helyes Z; Kereskai L; Sándor K; Pintér E; Pozsgai G; Tékus V; Bánvölgyi A; Németh J; Szuts T; Kéri G; Szolcsányi J
    Eur J Pharmacol; 2008 Jan; 578(2-3):313-22. PubMed ID: 17961545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.